Tag: <span>GLP-1</span>

Home / GLP-1
Post

GLP-1 drugs spark disagreements in Trump’s circle

From STAT’s Elaine Chen: GLP-1 drugs seem to be a source of contention among the people in President-elect Trump’s circle. Earlier this week, Elon Musk tweeted: “Nothing would do more to improve the health, lifespan and quality of life for Americans than making GLP inhibitors super low cost to the public.” It’s a sentiment he’s expressed several times before. (The...

December 16, 2024December 16, 2024by In News
Post

1 big thing: Supplement makers seize on GLP-1 boom

By Maya Goldman   Illustration: Shoshana Gordon/Axios   Some supplement companies are vying to get into the booming GLP-1 space, adding a new layer of complexity to accessing anti-obesity treatments.Why it matters: GLP-1s are expensive and in short supply. Supplements promoted with similar claims may be easier to come by, but experts warn they don’t have to meet...

December 11, 2024December 11, 2024by In News
Post

GLP-1 meds may lower clot risk in people with diabetes

by Ernie Mundell People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions in their odds for a dangerous blood clot, new research finds. The study found that folks with diabetes who were using the drugs lowered their odds for a form of clot called venous thromboembolism (VTE) by 20%, compared...

Post

As many as 1 in 5 people won’t lose weight with GLP-1 drugs, experts say

November 25, 2024 / 10:22 AM EST / AP Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle Griffin had no trouble getting them. The 38-year-old information technology worker from New Mexico had a prescription. Her pharmacy had the drugs in stock. And her health insurance covered all but $25 to $50 of...

Post

Stroke guidelines updated, with focus on women and GLP-1s

by Carole Tanzer Miller Women, especially those who had high blood pressure during pregnancy or entered menopause before age 45, are among those with a greater risk for stroke. They and other high-risk groups are the focus of new stroke prevention guidelines from the American Heart Association and American Stroke Association. The guidelines also suggest new GLP-1 weight-loss drugs...

Post

More than half of US adults could benefit from GLP-1 medications, researchers find

by Jacqueline Mitchell, Beth Israel Deaconess Medical Center Semaglutide Eligibility Among US Adults. Credit: JAMA Cardiology (2024). DOI: 10.1001/jamacardio.2024.4657 In a new analysis of national data, researchers at the Richard A. and Susan F. Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center (BIDMC) estimated that 137 million U.S. adults, more than half of all adults,...

Post

Side Effects of GLP-1 Drugs: What Doctors Should Know

Debbie Koenig November 21, 2024 Added to Email Alert Just a few years after some TikTok videos spiked the demand, one in eight US adults has tried Ozempic (semaglutide) or another drug in its class. Glucagon-like peptide 1 (GLP-1) receptor agonist medications have revolutionized obesity medicine. But they’re not without problems. In the early days of the...

Post

GLP-1 receptor agonist and SGLT2 inhibitor prescribing in people with type 1 diabetes

About The Study: Prescribing for both glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 (SGLT2) inhibitors in a type 1 diabetes (T1D) population identified in a database increased between 2010 and 2023. Differences in characteristics of the overall T1D population and those newly prescribed the medications are often associated with elevated cardiorenal risk profiles, suggesting...

Post

‘Gift That Keeps Giving’: The Impact of GLP-1 in Asthma

Akshay B. Jain, MD: Welcome back to Medscape at ADA 2024, where Dr James Kim, primary care physician from Calgary, Alberta, will be joining me, Akshay Jain, an endocrinologist from Vancouver, Canada, in deciphering the key highlights at the ADA conference and bringing our own clinical twist into what the relevance would be for people like...

How Much Weight Can You Lose on a GLP-1 Drug? It Depends on These Factors
Post

How Much Weight Can You Lose on a GLP-1 Drug? It Depends on These Factors

Ozempic Insulin injection pen for diabetics and weight lossCarolina Rudah / Getty ImagesHow much weight a person loses on liraglutide or semaglutide depends on a number of different factors, new research found.The study found that the type of medication a person takes, the treatment indication, the dosage, and other factors can have an impact on...